Ann E. Kearns
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ann E. Kearns has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Sundeep Khosla
Department of Physiology and Biomedical Engineering Mayo Clinic Rochester Minnesota USA
3 shared publications Prabin Thapa
Divisions of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
2 shared publicationsRobert A. Wermers
Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN, USA; Department of Medicine, Mayo Clinic, Rochester, MN, USA
2 shared publications- Robert A. Wermers
Mayo College of Medicine, Mayo Clinic
2 shared publications - Assad Qureshi
Los Angeles Biomedical Research Institute, 1124 West Carson St, Torrance, CA, 90502, USA
1 shared publication - Brooke Dickens
Los Angeles Biomedical Research Institute, 1124 West Carson St, Torrance, CA, 90502, USA
1 shared publication
Latest Publications
- 9 December 2022
- Published by Elsevier in Endocrine Practice
- Vol. 29 (5) , 408-413
Managing Bone Health in Breast Cancer
- 9 December 2022
- Published by Elsevier in Endocrine Practice
- Vol. 29 (5) , 408-413
Managing Bone Health in Breast Cancer
- 1 May 2020
- Published by Elsevier in Endocrine Practice
- Vol. 26 (5) , 571-572
Osteoporosis Secondary Fracture Prevention: A United Voice
- 1 May 2020
- Published by Elsevier in Endocrine Practice
- Vol. 26 (5) , 571-572
Osteoporosis Secondary Fracture Prevention: A United Voice
- 1 January 2020
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 14 (1) , 55-59
Non-contrast cardiac CT-based quantitative evaluation of epicardial and intra-thoracic fat in healthy, recently menopausal women: Reproducibility data from the Kronos Early Estrogen Prevention Study
- 1 January 2020
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 14 (1) , 55-59
Non-contrast cardiac CT-based quantitative evaluation of epicardial and intra-thoracic fat in healthy, recently menopausal women: Reproducibility data from the Kronos Early Estrogen Prevention Study
- 25 June 2019
- Published by Wiley in Clinical Endocrinology
- Vol. 91 (3) , 464-470
Clinical characteristics and depression score response after parathyroidectomy in primary hyperparathyroidism
Objective: Several studies indicate that patients with primary hyperparathyroidism (PHPT) undergoing parathyroid surgery have improvement in mood and neuropsychological functioning. The current analysis aims to examine the relationship between biochemical and clinical variables and the improvement in depression scores and in specific symptoms, after parathyroidectomy.Design: A prospective observational case‐control study at a referral centre.Patients: Patients with PHPT undergoing parathyroidectomy (n = 88) or thyroid surgery (n = 85).Measurements: The Patient Health Questionnaire‐9 (PHQ‐9) was utilized to obtain depression scores at enrolment and 12 months after surgery. The changes in PHQ‐9 were analysed and correlated with baseline clinical and biochemical parameters.Results: At enrolment, there was no difference between the groups in the number with a depression diagnosis (PHPT 34.1%, thyroid surgery, 35.5%, P = 0.86). However, baseline PHQ‐9 scores were significantly higher in PHPT (median 7.5, range 0‐27) than thyroid surgery patients (median 3.0, range 0‐18, P < 0.0001). Following surgery, all PHQ‐9 scores, total and symptom group (cognitive, somatic) improved and were no longer different between PHPT (total PHQ‐9 median 2, range 0‐16) and thyroid (median 1, range 0‐14, P = 0.31) groups. Baseline parathyroid hormone level, but not calcium, had a weak relationship with change in PHQ‐9 score after parathyroid surgery (P = 0.003). Baseline PHQ‐9 score was correlated with change in PHQ‐9 score at 12 months after parathyroid surgery (P < 0.001).Conclusions: Depression scores improve in both somatic and cognitive domains after parathyroidectomy for PHPT and baseline severity of depression predicts the response.
- 25 June 2019
- Published by Wiley in Clinical Endocrinology
- Vol. 91 (3) , 464-470
Clinical characteristics and depression score response after parathyroidectomy in primary hyperparathyroidism
Objective: Several studies indicate that patients with primary hyperparathyroidism (PHPT) undergoing parathyroid surgery have improvement in mood and neuropsychological functioning. The current analysis aims to examine the relationship between biochemical and clinical variables and the improvement in depression scores and in specific symptoms, after parathyroidectomy.Design: A prospective observational case‐control study at a referral centre.Patients: Patients with PHPT undergoing parathyroidectomy (n = 88) or thyroid surgery (n = 85).Measurements: The Patient Health Questionnaire‐9 (PHQ‐9) was utilized to obtain depression scores at enrolment and 12 months after surgery. The changes in PHQ‐9 were analysed and correlated with baseline clinical and biochemical parameters.Results: At enrolment, there was no difference between the groups in the number with a depression diagnosis (PHPT 34.1%, thyroid surgery, 35.5%, P = 0.86). However, baseline PHQ‐9 scores were significantly higher in PHPT (median 7.5, range 0‐27) than thyroid surgery patients (median 3.0, range 0‐18, P < 0.0001). Following surgery, all PHQ‐9 scores, total and symptom group (cognitive, somatic) improved and were no longer different between PHPT (total PHQ‐9 median 2, range 0‐16) and thyroid (median 1, range 0‐14, P = 0.31) groups. Baseline parathyroid hormone level, but not calcium, had a weak relationship with change in PHQ‐9 score after parathyroid surgery (P = 0.003). Baseline PHQ‐9 score was correlated with change in PHQ‐9 score at 12 months after parathyroid surgery (P < 0.001).Conclusions: Depression scores improve in both somatic and cognitive domains after parathyroidectomy for PHPT and baseline severity of depression predicts the response.
- 1 August 2016
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 118, 77-78
Recurrent euglycemic diabetic ketoacidosis after discontinuation of sodium-glucose cotransporter 2 inhibitor
- 1 August 2016
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 118, 77-78
Recurrent euglycemic diabetic ketoacidosis after discontinuation of sodium-glucose cotransporter 2 inhibitor
- 29 January 2016
- Published by Springer Nature
- p. 111-116
Medical Management of Primary Hyperparathyroidism
- 29 January 2016
- Published by Springer Nature
- p. 111-116
Medical Management of Primary Hyperparathyroidism
- 29 January 2016
- Published by Springer Nature
- p. 11-18
Severe Primary Hyperparathyroidism
- 1 January 2016
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 91 (1) , e1-e6
69-Year-Old Woman With Confusion and Fatigue
- 1 January 2016
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 91 (1) , e1-e6
69-Year-Old Woman With Confusion and Fatigue